David Scheer, Director at Aegerion Pharmaceuticals, Inc. (AEGR), bought 10,000 shares at $15.11 ($153K) on 2011-03-10, disclosed to the SEC on 2011-03-14.
Open-market purchase of $153k AEGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.11 | 3,994 | $60K | 39.5% |
| 2 | $15.36 | 6,006 | $92K | 60.5% |
| Total | $15.26 avg | 10,000 | $153K | 100% |
| Filing → |
| TNGN | BUY | 2010-04-15 | $100K | — | Filing → |